Peptides announces the release of the updated and expanded 2025 edition of the guidebook «Complex Application of Peptides Products» specially adapted for practical use across the European market.
Give your eyes the care they deserve. Pinalex Tab — bringing clarity to your view of the world.
Subscribe to mailing and get the latest news and discounts of our store.>
Scientific lecture "Peptides in complex therapy of musculoskeletal pathology"
Dear partners and friends!
Today, as a part of our section “SIC”, which combines the results of the research collaboration of the Peptides specialists and the researchers from Saint-Petersburg Institute of bioregulation and gerontology, we are introducing a new lecture with a new theme - Peptides in complex therapy of musculoskeletal pathology: clinical and molecular aspects.
The lecture is prepared by N. Linkova - Doctor of Biological Sciences, professor, Head of Laboratory of Molecular Mechanisms of Agieng in Saint-Petersburg Institute of bioregulation and gerontology, leading researcher in research and laboratory of drug delivery system developing in FSBI “Saint-Petersburg Research Institute of Phthisiopulmonology” of the Ministry of Healthcare of the Russian Federation, author of more than 400 scientific publications. The lecture examines the effectiveness of The Peptides’ preparations in the complex therapy of musculoskeletal diseases.
You can get acquainted with the text of the lecture in detail following the link: read the report here.
We invite you to read the text of the lecture below.
Wishing you good health, sunny spirits, and a wonderful holiday surrounded by your loved ones! Please note our online store’s holiday schedule:
We are always delighted to share new informational products with you. We present methodological guidelines developed by Peptides Company experts: "Enhancing the Reserve Capacity of the Body in Fitness Club Members and Athletes Using Peptide and Non-Peptide Bioregulators"
Kidney diseases are a global health challenge, affecting 10-20% of the population and significantly impacting quality of life. Therefore, our new research article in the SIC project focuses on the use of peptide bioregulators (such as Pielotax, Ovagen, and Renefort) in the prevention and treatment of kidney pathologies.
